BeStock  

Supernus Pharmaceuticals SUPN

US equityMarket cap rank #1870Drug Manufacturers - Specialty & Generic
$28.61 +$0.26 (+0.92%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $28.00 -2.13%
Open$28.39
Prev close$28.35
Day range$28.15 – $29.51
Volume2.83M
Market cap$5.94B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership86.1%-21.36 pts vs. prior quarter
Institutions holding542+135 vs. prior quarter
Insider trades (recent)20 buys / 26 sellsNet selling
Short interest7.93% of floatDays to cover 3.4 · as of 30 Oct 2026
Short-sale volume share25.3%5-day average of daily volume

Short-sale volume as % of daily volume

-3%10%22%35%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$21.86M (11 inflow days, 9 outflow days).

Net flow by order size, last 20 sessions

+$19.0MSuper+$2.8MBig+$6.4MMid−$1.2MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 22.5% of shares outstanding.

Largest holders

  • BlackRock8.97%
  • Vanguard Portfolio Management, LLC3.36%
  • Millennium Management LLC3.05%
  • Vanguard Capital Management, LLC2.55%
  • Armistice Capital LLC4.55%
  • State Street Global Advisors2.43%
  • Fuller & Thaler Asset Management, Inc.2.22%
  • Two Seas Capital LP1.77%

By investor type

  • Mutual Fund55.95%
  • Hedge Fund23.48%
  • Individual/Insider3.09%
  • Public Company2.61%
  • VC/PE Fund1.78%
  • Government Pension Fund1.33%
  • Private Company0.53%
  • Insurance Company0.31%

Reported short interest has risen from 7.14% to 7.93% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Jack Khattar Individual/Insider 2026/Q3 +3,413,555 1.6%
Westfield Capital Management Company, L.P. Mutual Fund 2026/Q3 +2,853,945 1.9%
Assenagon Asset Management S.A. Mutual Fund 2026/Q3 +1,999,416 1.7%
Westchester Capital Management, LLC Mutual Fund 2026/Q3 +775,856 0.4%
Danske Capital AS (Estonia) Mutual Fund 2026/Q3 +524,489 0.5%
Squarepoint OPS LLC Hedge Fund 2026/Q3 +362,126 0.2%
Morgan Stanley Public Company 2026/Q3 +246,586 1.8%
Public Sector Pension Investment Board Government Pension Fund 2026/Q3 +232,531 0.3%
BNP Paribas Financial Markets SNC Private Company 2026/Q3 +232,315 0.2%
Two Seas Capital LP Hedge Fund 2026/Q3 +191,579 1.8%
Millennium Management LLC Hedge Fund 2026/Q3 +4,244,706 3.1%
Point72 Asset Management, L.P. Hedge Fund 2026/Q3 +1,155,696 0.6%
Two Sigma Investments, LP Hedge Fund 2026/Q3 +913,150 2.0%
T. Rowe Price Group, Inc. Mutual Fund 2026/Q3 +816,160 0.5%
Armistice Capital LLC Hedge Fund 2026/Q3 +750,854 4.6%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
11 Aug 2026 Jack Khattar Founder, President, CEO, Secretary & Director Derivative Exercise and Sale -12,642 $46.57 2,216,451
11 Aug 2026 Jack Khattar Founder, President, CEO, Secretary & Director Derivative Exercise and Retained +17,207 – 2,216,451
11 Aug 2026 Timothy Dec Senior Vice President Derivative Exercise and Sale -604 $46.57 9,129
11 Aug 2026 Timothy Dec Senior Vice President Derivative Exercise and Retained +646 – 9,129
11 Aug 2026 Padmanabh Bhatt Chief Scientific Officer & Senior VP of Intellectual Property Derivative Exercise and Sale -1,158 $46.57 18,637
11 Aug 2026 Padmanabh Bhatt Chief Scientific Officer & Senior VP of Intellectual Property Derivative Exercise and Retained +1,342 – 18,637
11 Aug 2026 Jonathan Rubin Senior VP of Research & Development and Chief Medical Officer Derivative Exercise and Sale -363 $46.57 13,979
11 Aug 2026 Jonathan Rubin Senior VP of Research & Development and Chief Medical Officer Derivative Exercise and Retained +387 – 13,979
11 Aug 2026 Frank Mottola Senior VP & Chief Technology Operations Officer Derivative Exercise and Sale -797 $46.57 19,544
11 Aug 2026 Frank Mottola Senior VP & Chief Technology Operations Officer Derivative Exercise and Retained +853 – 19,544
28 Jul 2026 Jack Khattar Founder, President, CEO, Secretary & Director Other Derivative Acquisition +29,849 – 29,849
28 Jul 2026 Timothy Dec Senior Vice President Other Derivative Acquisition +1,250 – 1,250
28 Jul 2026 Padmanabh Bhatt Chief Scientific Officer & Senior VP of Intellectual Property Other Derivative Acquisition +2,500 – 2,500
28 Jul 2026 Jonathan Rubin Senior VP of Research & Development and Chief Medical Officer Other Derivative Acquisition +750 – 750
28 Jul 2026 Frank Mottola Senior VP & Chief Technology Operations Officer Other Derivative Acquisition +1,650 – 1,650
17 Mar 2026 Padmanabh Bhatt Chief Scientific Officer & Senior VP of Intellectual Property Derivative Exercise and Sale -107,250 $50.73 17,044
16 Mar 2026 Padmanabh Bhatt Chief Scientific Officer & Senior VP of Intellectual Property Intent to Sell (Form 144) -57,250 $50.21 –
15 Mar 2026 Padmanabh Bhatt Chief Scientific Officer & Senior VP of Intellectual Property Intent to Sell (Form 144) -50,000 $49.91 –
12 Mar 2026 Jack Khattar Founder, President, CEO, Secretary & Director Other Acquisition +12,500 – 2,199,244
12 Mar 2026 Jack Khattar Founder, President, CEO, Secretary & Director Other Disposition -12,500 – 2,199,244

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 4,619,509 7.9% 3.4
15 Oct 2026 4,043,677 6.9% 4.9
30 Sep 2026 4,985,929 8.6% 7.4
15 Sep 2026 4,989,421 8.6% 8.7
31 Aug 2026 4,671,860 8.0% 8.3
14 Aug 2026 4,147,629 7.1% 2.8

Discussion

No comments yet — be the first to weigh in on SUPN.

Sign in to join the discussion.

Scroll to Top